Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome

NCT00821574 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Dyslypidaemia

Interventions

DRUG: Fluvastatin
DRUG: Valsartan
DRUG: Hydrochlorothiazide

Sponsor

Novartis